Skip to main content
. 2020 Oct 14;13:10453–10464. doi: 10.2147/OTT.S272553

Table 1.

Demographics and Clinical Characteristics of ccRCC Patients According to Their CD39 Expression

Parameters All Patients (n=367)
Low Expression (n=210) High Expression (n=157) p value
Age 0.815
 <60 years 243 (66.2) 138 (65.7) 105 (66.9)
 ≧60 years 124 (33.8) 72 (34.3) 52 (33.1)
Gender 0.805
 Male 2,48 (67.6) 143 (68.1) 105 (66.9)
 Female 119 (32.4) 67 (31.9) 52 (33.1)
Invasion deep 0.003*
 T1/T2 303 (82.6) 184 (87.6) 119 (75.8)
 T3/T4 64 (17.4) 26 (12.4) 38 (24.2)
Lymph node metastasis 0.127
 N0 322 (87.7) 189 (90.0) 133 (84.7)
 N1 45 (12.3) 21 (10.0) 24 (15.3)
Distant metastasis 0.002*
 M0 308 (83.9) 187 (89.0) 121 (77.1)
 M1 59 (16.1) 23 (11.0) 36 (22.9)
pTNM stage 0.004*
 I/II 288 (78.5) 176 (83.8) 112 (71.3)
 III/IV 79 (21.5) 34 (16.2) 45 (28.7)
ISUP grade 0.147
 1/2 175 (47.7) 107 (51.0) 68 (43.3)
 ¾ 192 (52.3) 103 (49.0) 89 (56.7)

Notes: Data expressed as count and percentage for categorical variables and were performed by Chi-square test. *p <0.05 between low-expression and high-expression groups.

Abbreviations: ccRCC, clear cell renal cell carcinoma; ISUP, International Society of Urological Pathology.